Accepted_test

Structure-guided identification of Baicalin exhibiting anti-Alzheimer’s effects via CLK1 inhibition

by Sumaiya Khan | Md Imtaiyaz Hassan | Asimul Islam | Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, India | Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, India | Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, India

Abstract ID: 724

Event: BGRS-abstracts

Sections: [Sym 3] Section “Pharmacology cheminformatics and chemical biology”

This study explores the structure-guided binding potential of Baicalin as an inhibitor of CLK1, a kinase implicated in the phosphorylation of tau protein, a hallmark of Alzheimer’s disease (AD). Using molecular docking, molecular dynamics simulations, and fluorescence spectroscopy, Baicalin was found to bind effectively to CLK1. A kinase inhibition assay revealed that Baicalin significantly inhibits CLK1 with an IC50 value of 12.04 μM. These results suggest that Baicalin could serve as a promising lead compound for developing CLK1 inhibitors, offering a new therapeutic strategy for AD and other tau-related disorders.